Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Industry:
Early Drug Development
Investors Number:
1.0
Last Funding Date:
2017-09-05
Technology:
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Founded Date:
1992-02-11
Headquarters:
New York, New York, United States
Total Funding:
407231243.0
Last Funding Type:
Post-IPO Debt
Employee Number:
101-250